Ethnic Disparities in Adherence to Antihypertensive Medications of Medicare Part D Beneficiaries

Department of General Internal Medicine, UT MD Anderson Cancer Center, Houston, Texas 77030, USA.
Journal of the American Geriatrics Society (Impact Factor: 4.57). 06/2012; 60(7):1298-303. DOI: 10.1111/j.1532-5415.2012.04037.x
Source: PubMed


To determine the level of adherence to medications and characteristics of Part D beneficiaries associated with higher levels of antihypertensive medication adherence.
Retrospective cohort study.
Medicare claims and Part D event files.
Medicare Part D enrollees with prevalent uncomplicated hypertension who filled at least one antihypertensive prescription in 2006 and two prescriptions in 2007.
Medication adherence was defined as an average medication possession ratio of 80% or greater. Potential factors associated with adherence evaluated were age, sex, race or ethnicity, socioeconomic factors, comorbidity, medication use, copayments, being in the coverage gap, and number of unique prescribers.
Overall adherence was 79.5% of 168,522 Medicare Part D enrollees with prevalent uncomplicated hypertension receiving antihypertensive medicines in 2007. In univariate analysis, adherence varied significantly according to most patient factors. In multivariable analysis, lower odds of adherence persisted for blacks (odds ratio (OR) = 0.53, 95% confidence interval (CI) = 0.51-0.55), Hispanics (OR = 0.58, 95% CI = 0.55-0.61), and other non-white races (OR = 0.80 95% CI = 0.75-0.85) than for whites. Greater comorbidity and concurrent medication use were also associated with poorer adherence. Adherence was significantly different across several geographic regions.
A number of associations were identified between patient factors and adherence to antihypertensive drugs, with significant differences in adherence according to ethnicity. Improving adherence could have significant public health implications and could improve outcomes specific to hypertension, as well as improving cost and healthcare utilization.

Download full-text


Available from: James S Goodwin, Jul 01, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Antecedentes: En los últimos años se ha observa-do un aumento en la prevalencia de hipertensión arterial (HTA), que incluso afecta a población rural e indígena. Sin embargo, no existen datos de la población pehuen-che, la que habita mayoritariamente en la comuna de Alto Biobio. Objetivos: Determinar la prevalencia de HTA en habitantes de comunidades pehuenches y su relación con características etnodemográficas y el estado nutricional. Métodos: Estudio de prevalencia, corte transversal, sobre una muestra de 400 individuos mayores de 15 años; la adquisición de datos se realizó entre mayo y oc-tubre de 2011. Se incluyen variables sociodemográficas, étnicas y clínicas, estas últimas de acuerdo a criterios diagnósticos del MINSAL. Resultados: La prevalencia de HTA corresponde al 24,5%; no pesquisamos diferencias estadísticamente sig-nificativas por sexo, etnia ni estado nutricional. En cam-bio, si las hubo por edad, donde las personas mayores te-nían una mayor prevalencia y gravedad de HTA que sus contrapartes más jóvenes; el 70,59% de los mayores de 65 años tenía HTA. De la misma forma, se aprecia un au-mento progresivo de las presiones diastólicas, sistólicas y medias con la edad. Solo el 32% de la población pre-viamente diagnosticada tenía presiones en rango normal. Conclusiones: La prevalencia de HTA en comunidades pehuenches es similar a la nacional, siendo la edad el único factor de riesgo asociado a este diagnóstico.
    Full-text · Article · Jan 2012
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Since its implementation in 2006, Medicare Part D has evolved from a program that offered basic access to covered drugs for beneficiaries to one that has the potential to affect patient outcomes. OBJECTIVES: The purpose of this article was to highlight key research findings on Medicare Part D published in 2012 and major public policy initiatives for Part D for 2013. METHODS: PubMed/MEDLINE was searched for research studies on Part D published in 2012 in biomedical/scientific, peer-reviewed, English-language journals. For policy updates, sources included the Federal Register, the 2013 Final Call Letter, guidance from the Centers for Medicare and Medicaid Services, and 2012 publications on Part D policy identified in PubMed. RESULTS: Part D has been associated with higher medication use and lower out-of-pocket (OOP) costs of many long-term medications; however, differences within subgroups of beneficiaries have been observed. Studies on health outcomes have been inconclusive. Part D policy changes in 2013 have addressed problems with the benefit, namely coverage of benzodiazepines and barbiturates; reducing coinsurance in the coverage gap; reducing fraud, waste, and abuse; medication therapy management program standardization; and an expanded appeals process. CONCLUSIONS: Research continues to suggest that Part D is effective in increasing medication utilization and lowering OOP costs. Further work is needed to clarify the effects of Part D on nondrug health care service utilization and health outcomes. Policy changes for 2013 addressed specific improvements in the Medicare Part D benefit while potentially generating cost-savings for Medicare and Medicaid. Future challenges include alleviating access burden to medications during the phase-out of the coverage gap, minimizing disparities among Part D beneficiaries, and coordinating the Part D benefit with Medicare parts A and B via Medicare Accountable Care Organizations. A more integrated and coordinated Medicare benefit among all of its components would benefit overall health outcomes and increase cost-savings.
    No preview · Article · Mar 2013 · Clinical Therapeutics
  • [Show abstract] [Hide abstract]
    ABSTRACT: Medication nonadherence is a significant public health problem that affects the health and well-being of older Americans while burdening the US healthcare system. Pharmacy claims data have gained importance in deriving objective medication (re)fill adherence measures; however, little is known about application of such measures in older Americans. The objective of this study was to assess the types and characteristics of pharmacy claims-derived medication (re)fill adherence measures used in older Americans. A comprehensive literature search strategy was employed to identify all articles using pharmacy claims data to measure (re)fill adherence to prescription medications in older Americans aged 65+ years. Included were articles reporting original research studies conducted and published in the USA in English between 1 January 2000 and 1 November 2012. The basic search used multiple key terms indicating adherence, combined with the term "medication" and the term "pharmacy claims or administrative claims." Due to the variety of measure names used in the literature, a more specific search was added to repeat the basic search for 29 previously used medication (re)fill adherence measure names. Articles identified through the database search were manually reviewed to select only articles meeting the inclusion criteria. The search resulted in a total of 36 articles. Information on medication (re)fill measurements were extracted and summarized. The 36 articles used 20 differently named measures under the three main concepts: medication adherence, persistence, and discontinuation. Measures of medication adherence cumulatively assessed the proportion of time at which medications were (not) filled over a predefined observation period (e.g., medication possession ratio). Measures of medication persistence assessed the continuity of medication filling over a specified time period, while medication discontinuation measures focused on termination of medication (re)fills. Overall, almost two thirds of all identified articles used a single medication (re)fill adherence measure. Among them, 77 % used a medication possession measure. The term "medication possession ratio" (MPR) was used most frequently (65 %), followed by the "proportion of days covered" (PDC; 30 %). No single measure can be generally recommended for the use in older Americans. The challenges in using pharmacy claims-based medication (re)fill adherence measures in older Americans include a lack of consensus terminology and algorithms among measures of the same concepts, insufficient transparency of individual measure operationalization, and inadequate consideration of unique characteristics of the older population, such as temporary nursing home care. Although medication (re)fill adherence measures may be well suited for measuring medication adherence in older Americans, little guidance is available on how to use them in this population. Further efforts need to be given to the development and standardization of pharmacy claims-based medication (re)fill measures that are specifically tailored toward use in older Americans.
    No preview · Article · Apr 2013 · Drugs & Aging
Show more

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.